Showing grants tagged "Drug Policy Reform"

We’re open to supporting safe bets, like direct cash transfers to the world’s poorest people, as well as high-risk, high-reward projects, like minimizing risks from potentially world-changing science and technology. Read more about how we choose what to fund here.

Topics

Click a topic below to filter results for this section.

  1. MAPS — Randomized Controlled Phase 3 Trial for PTSD therapy (2019)

    Award Date:
    08/2019
    Amount:
    $500,000
    Drug Policy Reform

  2. Usona Institute — Psilocybin Trial for Depression Therapy

    Award Date:
    02/2019
    Amount:
    $500,000
    Drug Policy Reform

  3. MAPS — Randomized Controlled Phase 3 Trial for PTSD therapy (2018)

    Award Date:
    08/2018
    Amount:
    $500,000
    Drug Policy Reform

  4. Usona Institute — Phase 3 Trial for Depression Therapy

    Award Date:
    02/2018
    Amount:
    $500,000
    Drug Policy Reform

  5. Drug Policy Alliance — General Support (2017)

    Award Date:
    09/2017
    Amount:
    $300,000
    Drug Policy Reform

  6. MAPS — Randomized Controlled Phase 3 Trial for PTSD therapy (2017)

    Award Date:
    08/2017
    Amount:
    $500,000
    Drug Policy Reform

  7. Heffter Research Institute — General Support

    Award Date:
    09/2016
    Amount:
    $100,000
    Drug Policy Reform

  8. Drug Policy Alliance — General Support

    Award Date:
    08/2016
    Amount:
    $150,000
    Drug Policy Reform

  9. Heffter Research Institute — General Support

    Award Date:
    12/2015
    Amount:
    $100,000
    Drug Policy Reform

  10. Georgetown University — Public Health and Cannabis Legalization

    Award Date:
    08/2015
    Amount:
    $250,000
    Drug Policy Reform